CoChat

TGR 5 signaling reduces neuroinflammation during hepatic encephalopathy

Open access
McMillin, Matthew, Frampton, Gabriel, Tobin, Richard, Dusio, Giuseppina, Smith, Jenny, Shin, Hope, Newell‐Rogers, Karen, Grant, Stephanie, DeMorrow, Sharon · 2015 · Journal of Neurochemistry
Cited by 126

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Hepatic encephalopathy (HE) is a serious neurological complication of acute and chronic liver failure. Expression of the neurosteroid/bile acid receptor Takeda G protein‐coupled receptor 5 (TGR 5) has been demonstrated in the brain and is thought to be neuroprotective. However, it is unknown how TGR 5 signaling can influence the progression and associated neuroinflammation of HE. HE was induced in C57Bl/6 mice via intraperitoneal injection of azoxymethane (AOM) and tissue was collected throughout disease progression. TGR 5 expression was elevated in the frontal cortex following AOM injection in mice. The cellular localization of TGR 5 was found in both neurons and microglia in the cortex of C57Bl/6 mice. Central infusion of the TGR 5 agonist, betulinic acid, prior to AOM injection delayed neurological decline, increased cortical cyclic adenosine monophosphate concentrations, reduced microglia activation and proliferation, and reduced proinflammatory cytokine production. Betulinic acid treatment in vitro reduced the neuronal expression of chemokine ligand 2, a chemokine previously demonstrated to contribute to HE pathogenesis. Lastly, treatment of the microglia cell line EOC‐20 with conditioned media from betulinic acid‐treated primary neurons decreased phagocytic activity and cytokine production. Together, these data identify that activation of TGR 5, which is up‐regulated during HE, alleviates neuroinflammation and improves outcomes of AOM‐treated mice through neuron and microglia paracrine signaling. image This study supports that betulinic acid infusion into the brain during hepatic encephalopathy reduces the release of the neuronal cytokine CCL2 and subsequently inhibits proinflammatory cytokine release from microglia. This improves neurological outcomes in a mouse model of hepatic encephalopathy and identifies a potential therapeutic target for management of this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13243

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 126

Metadata

Authors
McMillin, M., Frampton, G., Tobin, R., Dusio, G., Smith, J., Shin, H., Newell‐Rogers, K., Grant, S., & DeMorrow, S.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2015-09-10
Volume
135
Issue
3
Pages
565-576
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1852294817
Cited by
126
References
9
FWCI
3.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.